Antibody

4개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved4 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleHighlight TherapeuticsPhase 2

pembrolizumab (Keytruda, BO-112 with pembrolizumab)

Colorectal Cancer; Gastric Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#GastricCancer+1
Trials 1Status Discontinued
AntibodyLimited DatastaleProthena Biosciences Ltd.Phase 3

Birtamimab (Birtamimab)

Light Chain (AL) Amyloidosis · Light Chain (AL) Amyloidosis

#LightChainALAmyloidosis#Antibody#Phase3#monoclonal-antibody#Prothena
Trials 1Status Discontinued
AntibodyLimited DatastaleInstitute of Hematology & Blood…Phase 2

CM336 Plus Isatuximab (CM336 Plus Isatuximab)

Multiple Myeloma (MM); Multiple Myeloma Light Chain Induced Renal Insufficiency · Multiple Myeloma (MM)

#MultipleMyelomaMM#Antibody#Phase2#monoclonal-antibody#MultipleMyelomaLightChainInduced+1
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenPreclinical

daratumumab (Darzalex, Dratumumab / Hyaluronidase Injection [Darzalex Faspro])

Light Chain (AL) Amyloidosis · Light Chain (AL) Amyloidosis

#LightChainALAmyloidosis#Antibody#Preclinical#monoclonal-antibody#Janssen
Trials 1Status Recruiting